Restoring Hearing and Natural Communication with a Single Treatment
Through precise, locally delivered gene therapies designed to restore function by reaching the cells that matter most.
Who We Are
Rethinking What’s Possible
Communication shapes how we connect, learn, and experience the world. At Skylark Bio, we develop genetic medicines designed to help the body function as intended and restore the biological processes that make communication possible.
Beginning with genetic hearing loss, we are advancing gene therapies that combine precise delivery with targeted access to disease-relevant cells and building a genetic medicines platform to address a broad range of genetically defined, single-gene diseases.
Hearing loss affects 3 to 4 out of every 1,000 children; genetic factors contribute to nearly 50% of cases.
The Problem
Current Treatments Do Not Replicate the Experience of Natural Communication
While hearing aids and cochlear implants help patients access sound, they do not address the underlying cause of disease, cannot fully restore natural hearing, and require lifelong dependence and maintenance.
The Solution
Precision Gene Therapies for Genetic Hearing Loss & Beyond
Skylark Bio’s locally delivered gene therapies are designed to restore the biological pathways that enable hearing, communication, connection, and engagement with the world.
The Impact
Scalable, Validated, and Broad-reaching
Beginning with hearing loss, Skylark is building a scalable, validated platform for precision-targeted, locally delivered gene therapies that address single-gene disorders. Leveraging advances in auditory medicine, we aim to develop transformative treatments for hearing loss and diseases of the central nervous system and beyond.
